Correlation Between Sino Biopharmaceutica and Aerovate Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sino Biopharmaceutica and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sino Biopharmaceutica and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sino Biopharmaceutical Ltd and Aerovate Therapeutics, you can compare the effects of market volatilities on Sino Biopharmaceutica and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sino Biopharmaceutica with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sino Biopharmaceutica and Aerovate Therapeutics.

Diversification Opportunities for Sino Biopharmaceutica and Aerovate Therapeutics

-0.03

Correlation Coefficient

Sino Biopharmaceutica  Aerovate Therapeutics

Good diversification

The 3 months correlation between Sino and Aerovate is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Sino Biopharmaceutical Ltd and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Sino Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sino Biopharmaceutical Ltd are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Sino Biopharmaceutica i.e., Sino Biopharmaceutica and Aerovate Therapeutics go up and down completely randomly.

Pair Corralation between Sino Biopharmaceutica and Aerovate Therapeutics

Assuming the 90 days horizon Sino Biopharmaceutical Ltd is expected to under-perform the Aerovate Therapeutics. In addition to that, Sino Biopharmaceutica is 1.21 times more volatile than Aerovate Therapeutics. It trades about -0.24 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  253.00  in Aerovate Therapeutics on October 20, 2024 and sell it today you would earn a total of  5.00  from holding Aerovate Therapeutics or generate 1.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Sino Biopharmaceutical Ltd  vs.  Aerovate Therapeutics

Sino Biopharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sino Biopharmaceutical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Aerovate Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sino Biopharmaceutica and Aerovate Therapeutics

The main advantage of trading using opposite Sino Biopharmaceutica and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sino Biopharmaceutica position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.

The idea behind Sino Biopharmaceutical Ltd and Aerovate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.